Oral Formulation of Insulin for Preterm Infants

Summary

The study will evaluate the effect of oral formulation of insulin on preterm infants, born between 26-33 weeks of pregnancy, weighing over 750 grams, who meet the inclusion and exclusion criteria established in this protocol.

Timeline

Start

2010-08

Primary completion

2013-08

Completion

2016-01

Drugs

Indications